Anjan Drug Pvt Ltd
Healthcare
PAG-led consortium to acquire majority stake in Anjan Drug
Hong Kong-based alternative investment firm PAG Asia Capital and its consortium partners CX Partners and Samara Capital have agreed to ......
Healthcare
PAG joins Indian PE firms for pharma platform, eyes second deal
Hong Kong-based alternative investment firm PAG Asia Capital has joined two Indian private equity firms to build a bulk-drugs platform ......
Healthcare
PE firms near club deal for majority stake in Anjan Drug
Two homegrown private equity firms have teamed up with an Asian alternative investment firm to strike a deal for Chennai-based ......
Healthcare
CX Partners, Samara in talks with drugmakers for club deal with two LPs
Homegrown private equity firms CX Partners and Samara Capital are scouting for investment opportunities in companies that make bulk drugs ......
Healthcare
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......
Healthcare
Evolvence India Life Sciences Fund fully exits Chennai drugmaker
Evolvence India Life Sciences Fund, the debut healthcare fund managed by private equity firm InvAscent, has fully exited its nine-year-old ......